Dr. Michael Andreeff from MD Anderson Cancer Center, Dr. Peter Valk from Erasmus MC in the Netherland, Gema Fuerte, MSc, Mission Bio
Mission Bio is a pioneer in high-throughput single-cell DNA multi-omic analysis and the technology is uncovering new insights into therapeutic resistance mechanisms and changing the way we think about tackling this large problem. It is our extreme pleasure to have Dr. Michael Andreeff from MD Anderson Cancer Center in the US and Dr. Peter Valk from Erasmus MC in the Netherlands join the Mission Bio team to discuss how single-cell multi-omics sequencing can be used to tackle therapy resistance.
Topics will include:
-Hematological malignancies and targeted therapies
-Treatment resistance and translational research
We look forward to having you join our expert panel discussion!